Article
Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 Val-Ala) p53.
British journal of cancer - 1 Jun 1998
Rauth S, Green A, Kichina J, Shilkaitis A
Abstract excerpt
Metastatic melanoma, compared with other cancers, appears to be unusual because of its low frequency of p53 mutations and prevalence of wild-type p53 protein in advanced malignancy. Here, we examined the effects of wild-type and mutated p53 (143 Val-Ala) on tumorigenic and metastatic potential of two human melanoma cell lines. The cell line UISO-MEL-4 contains wild-type p53 and is tumorigenic, whereas UISO-MEL-6...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
